161 related articles for article (PubMed ID: 36607399)
1. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.
Nakase H; Wagatsuma K; Nojima M; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Takeuchi K; Tamura S; Kinjo F; Ueno N; Naganuma M; Watanabe K; Moroi R; Nishimata N; Motoya S; Kurahara K; Takahashi S; Maemoto A; Sakuraba H; Saruta M; Tominaga K; Hisabe T; Tanaka H; Terai S; Hiraoka S; Takedomi H; Narimatsu K; Endo K; Nakamura M; Hisamatsu T
J Gastroenterol; 2023 Mar; 58(3):205-216. PubMed ID: 36607399
[TBL] [Abstract][Full Text] [Related]
2. Assessing the repercussions of COVID-19 pandemic on symptoms, disease management, and emotional well-being in patients with inflammatory bowel disease: a multi-site survey study.
El-Dallal M; Saroufim A; Systrom H; Ballou S; Farhoud A; Pasam RT; Gadupudi SS; Osman K; Chaudrey K; Cheifetz A; Feuerstein JD
Scand J Gastroenterol; 2022 Apr; 57(4):406-414. PubMed ID: 34894999
[TBL] [Abstract][Full Text] [Related]
3. Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey.
Cheema M; Mitrev N; Hall L; Tiongson M; Ahlenstiel G; Kariyawasam V
BMJ Open Gastroenterol; 2021 Feb; 8(1):. PubMed ID: 33579729
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
Trindade IA; Ferreira NB
Inflamm Bowel Dis; 2021 Jul; 27(8):1224-1229. PubMed ID: 33043977
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey.
Spagnuolo R; Larussa T; Iannelli C; Cosco C; Nisticò E; Manduci E; Bruno A; Boccuto L; Abenavoli L; Luzza F; Doldo P
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32823727
[No Abstract] [Full Text] [Related]
6. Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection.
Hernández Camba A; Ramos L; Madrid Álvarez MB; Pérez-Méndez L; Nos P; Hernández V; Guerra I; Jiménez N; Lorente R; Sierra-Ausín M; Ginard D; Varela Trastoy P; Arranz L; Cabello Tapia MJ; Zabana Y; Barreiro-de Acosta M;
Gastroenterol Hepatol; 2022 Nov; 45(9):668-676. PubMed ID: 34562522
[TBL] [Abstract][Full Text] [Related]
7. Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study.
Peng YL; Chang CH; Wei SC; Huang TY; Tai WC; Hsu WH; Wu DC; Yen HH; Tai CM; Chang CW; Lin WC; Wang HY; Lin CC; Kuo CJ; Chiu CT; Lin CP; Lee HC; Wu JF; Chung CS
J Formos Med Assoc; 2023 Oct; 122(10):1042-1049. PubMed ID: 37019722
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC
Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864
[TBL] [Abstract][Full Text] [Related]
9. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic.
Goodsall TM; Han S; Bryant RV
J Gastroenterol Hepatol; 2021 Jun; 36(6):1550-1555. PubMed ID: 33063927
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Pandemic Increased Anxiety Among Patients with Inflammatory Bowel Disease: A Patient Survey in a Tertiary Referral Center.
Stone ML; Feng M; Forster EM
Dig Dis Sci; 2022 Jul; 67(7):2876-2881. PubMed ID: 34115232
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective.
Grunert PC; Reuken PA; Stallhofer J; Teich N; Stallmach A
J Crohns Colitis; 2020 Dec; 14(12):1702-1708. PubMed ID: 32564068
[TBL] [Abstract][Full Text] [Related]
12. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
Saibeni S; Scucchi L; Dragoni G; Bezzio C; Miranda A; Ribaldone DG; Bertani A; Bossa F; Allocca M; Buda A; Mocci G; Soriano A; Mazzuoli S; Bertani L; Baccini F; Loddo E; Privitera AC; Sartini A; Viscido A; Grossi L; Casini V; Gerardi V; Ascolani M; Ruscio MD; Casella G; Savarino E; Stradella D; Pumpo R; Cortelezzi CC; Daperno M; Ciardo V; Nardone OM; Caprioli F; Vitale G; Cappello M; Comberlato M; Alvisi P; Festa S; Campigotto M; Bodini G; Balestrieri P; Viola A; Pugliese D; Armuzzi A; Fantini MC; Fiorino G;
United European Gastroenterol J; 2020 Dec; 8(10):1228-1235. PubMed ID: 33070758
[TBL] [Abstract][Full Text] [Related]
13. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
Macaluso FS; Giuliano A; Fries W; Viola A; Abbruzzese A; Cappello M; Giuffrida E; Carrozza L; Privitera AC; Magnano A; Ferracane C; Scalisi G; Minissale MG; Giangreco E; Garufi S; Bertolami C; Cucinotta U; Graziano F; Casà A; Renna S; Teresi G; Rizzuto G; Mannino M; Maida M; Orlando A
Inflamm Bowel Dis; 2023 Feb; 29(2):217-221. PubMed ID: 35385102
[TBL] [Abstract][Full Text] [Related]
14. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
Moum KM; Moum B; Opheim R
Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, Efficiency, and Acceptability of Telemedicine for Inflammatory Bowel Disease Patients' Follow-Up Care during the COVID-19 Pandemic.
Ramos L; Reygosa C; Carrillo-Palau M; Alonso-Abreu I; González-Mendez Y; de la Barreda R; Amaral C; Hernández A; Benítez-Zafra F; Hernandez-Guerra M
Dig Dis; 2023; 41(4):574-580. PubMed ID: 36716727
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Bowel Disease and COVID-19: How Have Patients Coped So Far?
Schlabitz F; Teich N; Riesner-Wehner A; Böhm S; Greinert R; Eisenmann S; Michl P; Walldorf J
J Clin Gastroenterol; 2022 Feb; 56(2):e126-e130. PubMed ID: 33538442
[TBL] [Abstract][Full Text] [Related]
17. Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study.
Zingone F; Siniscalchi M; Savarino EV; Barberio B; Cingolani L; D'Incà R; De Filippo FR; Camera S; Ciacci C
J Med Internet Res; 2020 Nov; 22(11):e19574. PubMed ID: 33006945
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System.
Khan N; Mahmud N; Trivedi C; Reinisch W; Lewis JD
Gut; 2021 Sep; 70(9):1657-1664. PubMed ID: 33753416
[TBL] [Abstract][Full Text] [Related]
19. Life changes, self-prevention, knowledge and mental health among inflammatory bowel disease patients during COVID-19 pandemic: a cross-sectional study.
He S; Xiao T; Xia Y
Front Public Health; 2024; 12():1416880. PubMed ID: 38932786
[TBL] [Abstract][Full Text] [Related]
20. Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey.
Martin Arranz E; Suarez Ferrer C; García Ramírez L; Rueda García JL; Sánchez-Azofra M; Poza Cordón J; Noci J; Zabana Y; Barreiro-de Acosta M; Martín-Arranz MD
Inflamm Bowel Dis; 2020 Jul; 26(8):1149-1154. PubMed ID: 32495826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
